Literature DB >> 9117806

Stability of tacrolimus in an extemporaneously compounded oral liquid.

P A Jacobson1, C E Johnson, N J West, J A Foster.   

Abstract

The stability of tacrolimus in an extemporaneously compounded oral liquid formulation was studied. A suspension was prepared by mixing the contents of commercially available 5-mg capsules of tacrolimus with equal amounts of Ora-Plus and Simple Syrup, NF, to make a final volume of 60 mL. The final concentration of tacrolimus in the suspension was 0.5 mg/mL. Six identical suspensions were prepared, placed in three glass and three plastic amber prescription bottles, and stored at room temperature (24-26 degrees C). Immediately after preparation and at 7, 15, 30, 45, and 56 days, samples were removed and assayed in duplicate by stability-indicating high-performance liquid chromatography. At least 98% of the initial tacrolimus concentrations remained in all suspensions throughout the study period. Color, order, and pH did not change appreciably over the study period. Tacrolimus 0.5 mg/mL compounded extemporaneously in equal amounts of Ora-Plus and Simple Syrup, NF, was stable at 24-26 degrees C for at least 56 days in both glass and plastic amber prescription bottles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117806     DOI: 10.1093/ajhp/54.2.178

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  3 in total

1.  Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes.

Authors:  Mihaela Friciu; Sarra Zaraa; Grégoire Leclair
Journal:  Can J Hosp Pharm       Date:  2017-02-28

2.  Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing.

Authors:  Kirk A Overhoff; Jason T McConville; Wei Yang; Keith P Johnston; Jay I Peters; Robert O Williams
Journal:  Pharm Res       Date:  2007-10-30       Impact factor: 4.200

3.  Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.

Authors:  Nastya Kassir; Line Labbé; Jean-Romain Delaloye; Mohamad-Samer Mouksassi; Anne-Laure Lapeyraque; Fernando Alvarez; Michel Lallier; Mona Beaunoyer; Yves Théorêt; Catherine Litalien
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.